Compare ANIX & SDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANIX | SDA |
|---|---|---|
| Founded | 1982 | 2007 |
| Country | United States | China |
| Employees | N/A | 544 |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 88.8M | 71.4M |
| IPO Year | 2013 | N/A |
| Metric | ANIX | SDA |
|---|---|---|
| Price | $2.74 | $0.78 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $8.67 | $4.75 |
| AVG Volume (30 Days) | 158.6K | ★ 1.4M |
| Earning Date | 05-27-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 12.82 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $210,000.00 | N/A |
| Revenue This Year | N/A | $12.01 |
| Revenue Next Year | N/A | $15.55 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.32 | $0.47 |
| 52 Week High | $5.46 | $2.93 |
| Indicator | ANIX | SDA |
|---|---|---|
| Relative Strength Index (RSI) | 51.99 | 41.70 |
| Support Level | $2.38 | $0.72 |
| Resistance Level | $3.12 | $2.18 |
| Average True Range (ATR) | 0.19 | 0.13 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 61.54 | 9.36 |
Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.
SunCar Technology Group Inc operates digital automotive aftersales market service platform and vehicle insurance technology platform. It develops and operates online platforms that connect drivers in China with a range of aftermarket automotive services and insurance coverage options from a nationwide network of service providers. These comprehensive digital systems are built on SunCar's multi-tenant, cloud-based platform. Revenues from its continuing operations are mainly generated from providing auto eInsurance services, technology services, and auto services.